study to evaluate pharmacokinetics and safety after oral administration of Plavix® and Astrix® in free combination and fixed-dose combination in healthy male volunteers
Not Applicable
Completed
- Conditions
- Not Applicable
- Registration Number
- KCT0000256
- Lead Sponsor
- Hanmi Pharm
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 64
Inclusion Criteria
Male
Age between 20 and 55
Signed informed consent
Exclusion Criteria
Has a history of hypersensitivity to IP ingredients
Hypotension or hypertension
Has a history of acute infection within 14days of screening
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method AUClast;Cmax
- Secondary Outcome Measures
Name Time Method AUCinf